Acute subdural hematoma (ASDH) is the most common intracranial traumatic lesion that requires surgical intervention. Although there is extensive published research on acute subdural, there remains uncertainty regarding mortality risk and functional outcomes for patients. This study aims to evaluate the effectiveness of contemporary scoring systems in different age groups of ASDH patients to predict functional outcomes.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Level of consciousness at time of injury
Timeframe: through study completion, an average of 1 year
Initial size of subdural hematoma
Timeframe: through study completion, an average of 1 year
Initial midline shift
Timeframe: through study completion, an average of 1 year
Chronic use of anti-clotting medication
Timeframe: once at time of admission
Trauma severity analyzed using Injury Severity Score (ISS).
Timeframe: once at time of admission
Severity of illness analyzed using Acute Physiology and Chronic Health Evaluation II score (APACHE II)
Timeframe: within 24 hours of admission
The Glasgow Outcome Scale (GOS) at the time of discharge from the Intensive Care (IC).
Timeframe: through study completion, an average of 1 year
The Glasgow Outcome Scale Extended (GOSE) evaluation of global disability and recovery after 6 months.
Timeframe: 6 months follow up
The Glasgow Outcome Scale Extended (GOSE) evaluation of global disability and recovery after 12 months.
Timeframe: 12 months follow up